Growth capital Tar Heel Capital is actively expanding its investment appetite with the new THC IV fund launched in October 2024, aiming to deploy over 500 million PLN over four years. This signals readiness for larger follow-on rounds and opportunity for portfolio companies seeking scale financing.

Polish SME focus The firm concentrates on the growing Polish SME sector and positions itself as a reliable partner to entrepreneurs, suggesting strong alignment with Polish market entrants and mid-market companies seeking strategic growth, buy-and-build opportunities, or exits.

Recent acquisitions Recent activity includes acquiring a majority stake in Med-Gastr Medical Center and integrating dental groups through the Dentity network, indicating a hands-on approach to value creation via strategic acquisitions and platform-building in healthcare services.

Revenue signals Current revenue range reported at $10M–$25M and a portfolio track record of profit growth for portfolio companies point to a proven value-creation model, making THC an attractive partner for firms aiming to accelerate profitability and scale.

Tech and marketing savvy Utilizes a modern tech stack and digital marketing tools (RSS, JSON-LD, MailerLite, PHP, SEO, analytics), indicating comfort with data-driven growth, digital marketing-enabled portfolio management, and potential for fintech or platform-enabled investment opportunities.